Skip to content

BLCO

Bausch + Lomb Corp.

NYSE · Healthcare · Medical - Instruments & Supplies · CA

$16.61
+0.73%
Ask drillr
Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open
$16.30
From 52W high
−10.70%
Volume
357028.00
Market cap
$5.93B
P/E (Fwd)
15.7x
EV/EBITDA
14.5x
P/E (TTM)
—
RSI (14)
45.5
1D Return
+0.73%
YTD Return
−3.07%
SummaryUpdated Jun 1, 2026

Bausch + Lomb Corporation (NYSE:BLCO) is a global eye health company with roots dating back to 1853, making it one of the oldest and most established names in vision care. Originally founded as an optical goods company in Rochester, New York, Bausch + Lomb has evolved into a comprehensive eye health enterprise. The company went public in May 2022 following a spinoff from Bausch Health Companies, establishing itself as an independent publicly traded entity focused exclusively on eye care products and services. Today, the company operates from its headquarters in Vaughan, Canada, and serves customers worldwide across three distinct business segments covering the entire spectrum of eye health needs.

Similar companies

Latest newsMore news →